Venetoclax‐based non‐intensive induction followed by allogenic stem‐cell transplantation in elderly acute myeloid leukemia patients with adverse cytogenetics
VEN-based treatment was found to be effective in high risk AML can be considered as an alternative to IC in patients aged 60-75 with adverse cytogenetics.
Authors
- Evelyne D’Incan
- Aude Charbonnier
- Julien Mozziconacci (ORCID: https://orcid.org/0000-0001-5652-0302)
- Bilal Mohty
- Sylvain Garciaz (ORCID: https://orcid.org/0000-0002-0081-1255)
- Anne‐Sophie Alary (ORCID: https://orcid.org/0000-0001-9336-6869)
- Julia Gilhodes (ORCID: https://orcid.org/0000-0002-0083-2582)
- Antoine Ittel (ORCID: https://orcid.org/0000-0001-5067-575X)
- Yosr Hicheri (ORCID: https://orcid.org/0000-0002-4508-9921)
- Norbert Vey (ORCID: https://orcid.org/0000-0001-7027-040X)
- Colombe Saillard (ORCID: https://orcid.org/0000-0002-3984-5612)
- Amel Soua
- Jean‐Marie Boher (ORCID: https://orcid.org/0000-0002-5395-839X)
- Raynier Devillier (ORCID: https://orcid.org/0000-0002-4045-8310)
- Alexandre Iat (ORCID: https://orcid.org/0009-0009-5370-9025)
- Anne‐Catherine Lhoumeau
- Véronique Gelsi‐Boyer
- Anne Murati (ORCID: https://orcid.org/0000-0002-2140-7868)
- Camille Rouzaud (ORCID: https://orcid.org/0000-0001-9292-4566)
- Jérôme Rey
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Aix-Marseille Université (FR)
- Institut Paoli-Calmettes (FR)
Publication Details
- Journal
- European Journal Of Haematology
- Published
- 2024-08-11
- DOI
- https://doi.org/10.1111/ejh.14290
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00